Validation and performance of a multiplex serology assay to quantify antibody responses following SARS-CoV-2 infection or vaccination

General interest Vaccines

Keywords: • antibodies • COVID-19 • electrochemiluminescence • immunoassay • SARS-CoV-2 • serology

In this report, we provide an overview of the strategy and validation results for the multiplex SARS-CoV-2 ECL serology assay and demonstrate the assay’s applicability to complement clinical diagnostics

Click here to download the full article

 

In association with:

 

 

 

Source: Wilkins D, Aksyuk A, Ruzin A et al. Validation and performance of a multiplex serology assay to quantify antibody responses following SARS-CoV-2 infection or vaccination. Clin Transl Immunol, 11(4),  doi: 10.1002/cti2.1385 (2022)

 

This article is a part of the Bioanalysis Zone Spotlight feature on vaccine assay development. For more expert opinions on this topic, visit our feature homepage

Visit the feature